RBC Affirms Aerie Pharma (AERI) at 'Outperform'; Positive on Data from Another Rho Kinase Inhibitor

October 18, 2016 7:59 AM EDT Send to a Friend
RBC Capital is out positive on Aerie Pharmaceuticals (Nasdaq: AERI) amid a recent AAO update. The firm has AERI ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login